Pyoderma gangrenosum: a report of 21 cases

被引:54
作者
Mlika, RB
Riahi, I
Fenniche, S
Mokni, M
Dhaoui, MR
Dess, N [1 ]
Dhahri, ABO
Mokhtar, I
机构
[1] Mil Hosp Tunis, Dept Dermatol, Tunis 1089, Tunisia
[2] Hop La Rabta, Dept Dermatol, Tunis, Tunisia
[3] Hop Habib Thameur, Dept Dermatol, Tunis, Tunisia
关键词
D O I
10.1046/j.1365-4362.2002.01329.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Pyoderma gangrenosum (PG) is an uncommon, destructive, cutaneous ulceration, belonging to the neutrophilic disease spectrum. It is associated with systemic disease in 50% of cases. Methods We report a retrospective study of 21 cases of PG. All cases studied fulfilled the following criteria: (i) clinical features of PG; (ii) histopathology consistent with a diagnosis of PG, and excluding other specific dermatoses. Results The average age of our patients was 41.8 years. The male to female ratio was 1.1. The typical ulcerative variant was found in 17 patients, bullous PG in two patients, and the granulomatous variant in two patients. Sixty-two per cent of our patients had lesions on their lower legs. Two patients had neutrophilic pulmonary involvement concurrent with the ulcers. An association with other internal diseases was noted in 12 patients. Histopathologic study showed vasculitis in 13 patients. Of these, 11 were leukocytoclastic and the others predominantly lymphocytic. Conclusions PG is a rare disease, with the ulcerative variant being most frequent. The lower legs are the most commonly affected sites. The recurrence rate in our study was about 46% regardless of the treatment prescribed. Pulmonary involvement was fatal in two patients.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 14 条
[1]   Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: A rarely recognized extracutaneous manifestation of a neutrophilic dermatosis [J].
Brown, TS ;
Marshall, GS ;
Callen, JP .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (01) :108-112
[2]   Pyoderma (echthyma) gangrenosum - Clinical and experimental observations in five cases occurring in adults [J].
Brunsting, LA ;
Goeckerman, WH ;
O'Leary, PA .
ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1930, 22 (04) :655-680
[3]  
CHEVRANTBRETON J, 1989, ANN DERMATOL VENER, V116, P577
[4]   Treatment of pyoderma gangrenosum [J].
Chow, RKP ;
Ho, VC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (06) :1047-1060
[5]   Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression [J].
de Imus, G ;
Golomb, C ;
Wilkel, C ;
Tsoukas, M ;
Nowak, M ;
Falanga, V .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) :61-66
[6]  
DEWAZIERES B, 1991, REV MAL RESPIR, V8, P595
[7]  
FARRELL AM, 1998, BRIT J DERMATOL, V138, P205
[8]   Recalcitrant pyoderma gangrenosum treated with thalidomide [J].
Federman, GL ;
Federman, DG .
MAYO CLINIC PROCEEDINGS, 2000, 75 (08) :842-844
[9]   Multiple pulmonary nodules in association with pyoderma gangrenosum [J].
Kasuga, I ;
Yanagisawa, N ;
Takeo, C ;
Koga, M ;
Kiyokawa, H ;
Yonemaru, M ;
Ichinose, Y ;
Toyama, K .
RESPIRATORY MEDICINE, 1997, 91 (08) :493-495
[10]   Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis [J].
Marie, I ;
Levesque, H ;
Joly, P ;
Reumont, G ;
Courville, P ;
Baudrimont, M ;
Baubion, D ;
Cailleux, N ;
Courtois, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) :137-139